YK 11 MYANABOL

Androgen Receptor Modulator & Myostatin Inhibitor for Research

Optimised Research Labs YK‑11 Myanabol is a high‑purity investigational compound consisting of YK‑11, a **synthetic androgen receptor ligand with additional myostatin‑inhibiting properties**. It is formulated for laboratory research to explore pathways associated with **androgen receptor signalling, muscle differentiation, and myostatin regulation** — mechanisms of interest in muscle mass and recovery studies. 

Main Research Benefits of YK‑11 Myanabol

• Engages the **androgen receptor** with partial agonist activity potentially linked to anabolic signalling in muscle cells. 
• Associated with increased **follistatin expression**, a protein that may suppress myostatin — a key inhibitor of muscle growth. 
• Useful for studies focused on **muscle cell differentiation and protein synthesis pathways**. 
• Explores mechanisms that combine androgen receptor engagement with myostatin inhibition.
• Applicable in research designs investigating **body composition regulation and anabolic responses**. 

How YK‑11 Works (Research Mechanism)

YK‑11 is structurally distinct among androgen receptor modulators, possessing a **steroidal backbone** that allows it to bind to the androgen receptor while **strongly inducing follistatin expression** — a potent **inhibitor of myostatin**, a protein that limits muscle growth. 

In laboratory models, increased follistatin levels can reduce myostatin activity — a mechanism that is thought to enhance muscle cell growth and differentiation beyond what is typically seen with classical SARMs.

Product Features & Specifications

• Brand: Optimised Research Labs
• Compound: YK‑11 (Myanabol)
• Form: Capsules (typically 5 mg per capsule)
• Mechanism: Partial androgen receptor agonist & myostatin pathway modulator
• Use: Laboratory research use only — not approved for human or veterinary consumption

Suggested Research Usage

In controlled research protocols, YK‑11 is often evaluated for its effects on **anabolic signalling and pathways influencing muscle cell differentiation and protein synthesis**. Because of its potent activity, research designs typically adopt precise dosing and monitoring strategies to assess molecular responses over time. 

⚠️ Important: Optimised Research Labs YK‑11 Myanabol is supplied **for research and laboratory investigation only**. It is not approved as a therapeutic, dietary supplement, or for human/veterinary use. Always adhere to applicable legal regulations, safety standards, and institutional guidelines when handling investigational compounds.

Frequently Asked Questions

What is YK‑11 Myanabol?

YK‑11 Myanabol is an investigational compound that functions as a **partial androgen receptor agonist** and strongly induces **follistatin expression**, which in turn may suppress myostatin — a protein that limits muscle growth. How does YK‑11 differ from other SARMs?

While many SARMs act primarily through selective androgen receptor engagement, YK‑11 is unique in its **dual mechanism** involving both androgen receptor modulation and **myostatin inhibition via increased follistatin** expression — processes studied for muscle differentiation pathways. 

Is YK‑11 approved for human use?

No — YK‑11 is an investigational research compound not approved by regulatory authorities for human or veterinary use. It should be handled and studied only in appropriate laboratory settings. 

Investigate advanced anabolic and myostatin‑related signalling pathways with Optimised Research Labs YK‑11 Myanabol — a high‑purity research compound formulated for laboratory study of androgen receptor and muscle regulation mechanisms.